Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety
H. A. M. Kerstjens, E. Bleecker, E. Meltzer, T. Casale, E. Pizzichini, O. Schmidt, M. Engel, L. J. Bour, C. B. Verkleij, P. M. Moroni-Zentgraf, E. D. Bateman (Groningen, Alkmaar, Netherlands; Winston-Salem, San Diego, Omaha, United States Of America; Santa Catarina, Brazil; Koblenz, Ingelheim am Rhein, Biberach an der Riss, Germany; Cape Town, South Africa)
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. A. M. Kerstjens, E. Bleecker, E. Meltzer, T. Casale, E. Pizzichini, O. Schmidt, M. Engel, L. J. Bour, C. B. Verkleij, P. M. Moroni-Zentgraf, E. D. Bateman (Groningen, Alkmaar, Netherlands; Winston-Salem, San Diego, Omaha, United States Of America; Santa Catarina, Brazil; Koblenz, Ingelheim am Rhein, Biberach an der Riss, Germany; Cape Town, South Africa). Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety. Eur Respir J 2013; 42: Suppl. 57, 4629
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: